LANDFAR BIO-MEDICINE CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.29 CNY | -9.99% |
|
+3.37% | -28.53% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 200M 27.74M | Sales 2023 | 137M 18.94M | Capitalization | 3.61B 500M |
|---|---|---|---|---|---|
| Net income 2022 | -12M -1.66M | Net income 2023 | -28M -3.88M | EV / Sales 2022 | 18.2 x |
| Net Debt 2022 | 16.5M 2.28M | Net cash position 2023 | 451M 62.47M | EV / Sales 2023 | 23.1 x |
| P/E ratio 2022 |
-291
x | P/E ratio 2023 |
-129
x | Employees | 512 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.63% |
More Fundamentals
* Assessed data
More news
| 1 day | -9.99% | ||
| 1 week | +3.37% | ||
| Current month | +5.07% | ||
| 1 month | +5.87% | ||
| 3 months | +29.13% | ||
| 6 months | -29.45% | ||
| Current year | -28.53% |
1 week
8.29
10.67
1 month
6.2510.67
Current year
5.2612.18
1 year
5.2613.17
3 years
5.2624.97
5 years
5.2624.97
10 years
5.2636.97
| Managers | Title | Age | Since |
|---|---|---|---|
Chang Qiao You
CEO | Chief Executive Officer | 51 | 20-06-16 |
Peng Bin Lin
DFI | Director of Finance/CFO | 51 | 15-01-26 |
Zhi Fu Li
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chang Qiao You
CEO | Chief Executive Officer | 51 | 20-06-16 |
Ping Zhao
BRD | Director/Board Member | 53 | 21-12-28 |
Yuan Chen
BRD | Director/Board Member | 43 | 17-11-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 7.67 | -7.48% | 31,326,890 |
| 24-05-14 | 8.29 | -9.99% | 3,203,500 |
| 24-05-13 | 9.21 | -9.97% | 2,655,800 |
| 24-05-10 | 10.23 | +5.46% | 46,279,290 |
| 24-05-09 | 9.7 | +9.98% | 2,012,401 |
End-of-day quote Shenzhen S.E., May 13, 2024
More quotes
Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.
Calendar
2024-05-24
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -28.53% | 378M | |
| -16.80% | 8.79B | |
| +66.05% | 4.19B | |
| -4.03% | 2.48B | |
| -42.54% | 2.29B | |
| -5.69% | 1.97B | |
| -19.40% | 1.56B | |
| -40.24% | 1.22B | |
| +9.42% | 1.13B | |
| +18.74% | 933M |
- Stock Market
- Equities
- 000504 Stock